ÃÛÌÒÓ°Ïñ

Leadership at USDA’s Farm Service Agency (FSA) have responded to a request from National Bison Association to find a new path for relief for bison producers affected by Mycoplasma infection and mortality. In previous years, the FSA considered Mycoplasma to be a secondary infection in bison, which prevented producers from qualifying for reimbursement for death losses under the agency’s Livestock Indemnity Program (LIP).

A new laboratory will bring researchers from ÃÛÌÒÓ°Ïñ and South Dakota Mines together with industry partners to transition bench-scale bioprocessing and bioproducts research to the marketplace.

Through the generosity of two ÃÛÌÒÓ°Ïñ alumni, the university has established its first endowed faculty position in the College of Education and Human Sciences. The Tate Profilet and Mary DeJong Family Endowed Director of Early Childhood Education was formalized at an Oct. 22 investiture ceremony, paving the way for a new era of the early childhood education program at State.

A safe, localized treatment for chronic inflammation in the intestinal tract will move one step closer to helping patients reduce their risk of developing colon cancer, thanks to a three-year, $433,000 National Institutes of Health grant awarded to professor Hemachand Tummala of the Department of Pharmaceutical Sciences.

Assistant professor Anamika Prasad is the first mechanical engineering faculty member to receive the prestigious National Science Foundation CAREER award.

Putting people addicted to meth on the road to recovery is the goal of the Stigma, Treatment, Avoidance and Recovery in Time Program for Psychostimulant Support in Rural South Dakota.

Assistant professor Yue Zhou of the Department of Electrical Engineering and Computer Science, is leading a three-year, nearly $450,000 National Science Foundation project to determine how lithium metal improves battery performance.

Tummala, a professor and graduate program coordinator in pharmaceutical sciences, has more than 20 years of research experience in disease biology, immunology and drug delivery.

Chandrasekher is performing research that could lead to development of cornea-equivalents for transplantation purposes. Corneal transplantation, which is referred to as ‘keratoplasty’ in ophthalmology clinics, is the most common treatment for irreparable corneal damage. In most cases, only the diseased or injured section of the cornea is replaced.

The A research lab focuses on genomics. The human genome has all of the instructions necessary for one’s 30 trillion cells to function correctly. When mutated, the genome is also unfortunately responsible for myriad genetic disorders. The source of such mutations can be external, such as from exposure to UV rays or carcinogens.